What's new

Human medicines European public assessment report (EPAR): Uptravi, selexipag, Date of authorisation: 12/05/2016, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Uptravi, selexipag, Date of authorisation: 12/05/2016, Revision: 17, Status: Authorised

Mar 17, 2025 - 15:42
 0
Human medicines European public assessment report (EPAR): Uptravi, selexipag, Date of authorisation: 12/05/2016, Revision: 17, Status: Authorised
Human medicines European public assessment report (EPAR): Uptravi, selexipag, Date of authorisation: 12/05/2016, Revision: 17, Status: Authorised
Read More

Tags:

Previous Article

These Are The Used Cars You Would Buy With $10,000

Next Article

FERC reaffirms approval of Southeastern SEEM market

Related Posts

EMEA-003587-PIP01-24

EMEA-003587-PIP01-24

Feb 12, 2025  0

Human medicines European public assessment report (EPAR): Copalia HCT, amlodipine,valsartan,hydrochlorothiazide, Date of authorisation: 03/11/2009, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 12, 2025  0

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – October 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 October 2025, 10:00 (CEST) to 22 October 2025, 12:00 (CEST)

Meeting of the Executive Steering Group on Shortages an...

Feb 9, 2025  0